Enhancement of immune complex clearance by TNF-α in a murine model

Clinical Immunology and Immunopathology

Volumn 89, Issue 3, 1998, Pages 214-221

  Alves Rosa, M Fernanda ^a   Palermo, Marina S ^a   Isturiz, Martín A ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

Clearance; Immune complexes; TNF

Indexed keywords

LIPOPOLYSACCHARIDE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE KINETICS; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REPRODUCIBILITY; TISSUE DISTRIBUTION;

EID: 0032374084     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4610     Document Type: Article

References (29)

1. Halma C., Daha M. R., Van Es L. A. In vivo. Clin. Exp. Immunol. 89:1992;1-7.
2. Schifferly J. A., Taylor R. P. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35:1989;993-1003.
3. Frank M. M., Lawlet T., Hamburger M. I., Brown E. J. Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann. Int. Med. 98:1983;206-218.
4. Theofilopoulos A. N., Dixon F. J. Immunocomplexes in human diseases: A review. Am. J. Pathol. 100:1980;531-591.
5. Kabbash L., Brandwein S., Esdaile J., Danoff D., Fuks A., Shustes J. Reticuloendothelial system Fc receptor function in systemic lupus erythematosus. J. Rheumatol. 9:1982;374-379.
6. Walport M. J., Davies K. A. Complement and immune complexes. Res. Immunol. 147:1996;103-109.
7. Palermo M. S., Alves Rosa M. F., Fernández Alonso G., Isturiz M. A. Fcγ receptor-dependent clearance is enhanced following LPSin vivo. Immunology. 92:1997;536-543.
8. Gallay P., Jongeneel C. V., Barras C., Burnier M., Baugmarter J. D., Glauser M. P., Heumann D. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J. Immunol. 150:1993;5086-5093.
9. Forehand J. R., Pabst M. J., Phillips W. A., Johnston R. B. Lipopolysaccharides priming of human neutrophils for an enhanced respiratory burst. J. Clin. Invest. 83:1987;74-83.
10. Parrillo J. E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1993;1471-1477.
11. Waage A., Brandtzag P., Espevik T., Halstenen A. Current understanding of the pathogenesis of gram-negative septic shock. Infect. Dis. Clin. North Am. 5:1991;781-791.
12. Atkinson J. P., Frank M. M. Failure of cytotoxic agents to inhibit the clearance of sensitized erythrocytes. J. Reticuloendothel. Soc. 16:1974;122-130.
13. Wang A. M., Creasey A. A., Ladner M. B., Lin L. S., Strickler J., Van Arsdell J. N., Yamamaoto R., Mark D. F. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science. 228:1985;149-154.
14. Beutler B., Cerami A. Cachectin: More than a tumor necrosis factor. N. Engl. J. Med. 316:1987;379-385.
15. Albrecht H., Schook L. B., Jongeneel C. V. Nuclear migration of NF-κβ correlates with TNF-α mRNA accumulation. J. Inflammat. 45:1995;64-71.
16. Schifferly J. A. Complement and immune complexes. Res. Immunol. 147:1996;109-110.
17. Bemelmans M. H. A., Gouma D. J., Buurman W. A. LPS-induced sTNF-receptor releasein vivo. J. Immunol. 151:1993;5554-5562.
18. Barsig J., Kuster S., Vogt K., Dieter-Volk H., Tiegs G., Wendel A. Lipopolysaccharide-induced interleukin-10 in mice: Role of endogenous tumor necrosis factor a. Eur. J. Immunol. 25:1995;2888-2893.
19. Freundenberg M. A., Kumazawa V., Meding S., Langhorne J., Galanos C. Gamma interferon production in endotoxin responder and non-responder mice during infection. Infect. Immun. 59:1991;3484-3489.
20. Sivo J., Politis A. D., Vogel S. N. Differential effects of IFN-γ and glucocorticoids on FcγR gene expression in murine macrophages. J. Leukocyte Biol. 54:1993;451-457.
21. Witthaut R., Farhood A., Smith C. W., Jaeschke H. Complement and TNF contribute to Mac-1 (CD11/CD18) upregulation and systemic neutrophil activation during endotoxemiain vivo. J. Leukocyte Biol. 55:1994;105-111.
22. Erzurum S. C., Downey G. P., Doherty D. E., Schwab B. III, Elson E. L., Worthen G. S. Mechanisms of LPS-induced neutrophil retention. Relative contributions of adhesive and cellular mechanical properties. J. Immunol. 149:1992;154-162.
23. Petty H. R., Todd R. F. III. Integrins as promiscuous signal transduction devices. Immunol. Today. 17:1996;209-212.
24. Zhou M. J., Todd R. F. III, van de Winkel J. G. J., Petty M. R. Cocapping of the leukoadhesin molecule complement receptor type 3 and lymphocyte function-associated antigen 1 with Fcγ receptor III on human neutrophil. J. Immunol. 150:1993;3030-3041.
25. Jacob C., Mc Devitt H. Tumor necrosis factor-α in murine autoimmune lupus nephritis. Nature. 331:1988;356-358.
26. Gordon C., Wofsy D. Effects of recombinant tumor necrosis factor-α on immune function. J. Immunol. 144:1990;1753-1758.
27. Vassalli P. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10:1992;411-452.
28. Koeffler H. P., Gasson J., Ranyard J., Souza L., Shepard M., Munker R. Recombinant human TNF-α stimulates production of granulocyte colony-stimulating factor. Blood. 70:1987;55-59.
29. Nill M. R., Oberyszyn T. M., Ross M. S., Oberyszyn A. S., Robertson F. M. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. J. Leukocyte Biol. 58:1995;563-574.